全文获取类型
收费全文 | 1268篇 |
免费 | 200篇 |
国内免费 | 53篇 |
出版年
2024年 | 3篇 |
2023年 | 44篇 |
2022年 | 78篇 |
2021年 | 107篇 |
2020年 | 108篇 |
2019年 | 148篇 |
2018年 | 108篇 |
2017年 | 55篇 |
2016年 | 52篇 |
2015年 | 50篇 |
2014年 | 89篇 |
2013年 | 126篇 |
2012年 | 58篇 |
2011年 | 83篇 |
2010年 | 45篇 |
2009年 | 44篇 |
2008年 | 30篇 |
2007年 | 42篇 |
2006年 | 32篇 |
2005年 | 34篇 |
2004年 | 24篇 |
2003年 | 24篇 |
2002年 | 17篇 |
2001年 | 12篇 |
2000年 | 7篇 |
1999年 | 14篇 |
1998年 | 11篇 |
1997年 | 13篇 |
1996年 | 6篇 |
1995年 | 2篇 |
1994年 | 3篇 |
1993年 | 12篇 |
1992年 | 3篇 |
1991年 | 1篇 |
1990年 | 5篇 |
1989年 | 4篇 |
1988年 | 2篇 |
1987年 | 2篇 |
1986年 | 4篇 |
1985年 | 1篇 |
1984年 | 4篇 |
1983年 | 3篇 |
1982年 | 1篇 |
1981年 | 3篇 |
1980年 | 2篇 |
1979年 | 1篇 |
1978年 | 1篇 |
1977年 | 1篇 |
1975年 | 1篇 |
1974年 | 1篇 |
排序方式: 共有1521条查询结果,搜索用时 557 毫秒
81.
Soheila Moein Mostafa Vaghari-Tabari Durdi Qujeq Maryam Majidinia Seyed Mohammad Nabavi Bahman Yousefi 《Journal of cellular physiology》2019,234(4):3277-3293
Inflammatory bowel disease (IBD), as a chronic and recurrent inflammatory disorder, is caused by a dysregulated and aberrant immune response to exposed environmental factors in genetically susceptible individuals. Despite huge efforts in determining the molecular pathogenesis of IBD, an increasing worldwide incidence of IBD has been reported. MicroRNAs (miRNAs) are a set of noncoding RNA molecules that are about 22 nucleotides long, and these molecules are involved in the regulation of the gene expression. By clarifying the important role of miRNAs in a number of diseases, their role was also considered in IBD; numerous studies have been performed on this topic. In this review, we attempt to summarize a number of studies and discuss some of the recent developments in the roles of miRNAs in the pathophysiology, diagnosis, and treatment of IBD. 相似文献
82.
Reza Ranjbar Mojtaba Shafiee AmirReza Hesari Gordon A. Ferns Faezeh Ghasemi Amir Avan 《Journal of cellular physiology》2019,234(3):2277-2295
Inflammation is a normal part of the immune response to injury or infection but its dysregulation promotes the development of inflammatory diseases, which cause considerable human suffering. Nonsteroidal anti-inflammatory agents are the most commonly prescribed agents for the treatment of inflammatory diseases, but they are accompanied by a broad range of side effects, including gastrointestinal and cardiovascular events. The renin–angiotensin system (RAS) is traditionally known for its role in blood pressure regulation. However, there is increasing evidence that RAS signaling is also involved in the inflammatory response associated with several disease states. Angiotensin II increases blood pressure by binding to angiotensin type 1 (AT1) receptor, and direct renin inhibitors, angiotensin-converting enzyme (ACE) inhibitors and AT1 receptor blockers (ARBs) are clinically used as antihypertensive agents. Recent data suggest that these drugs also have anti-inflammatory effects. Therefore, this review summarizes these recent findings for the efficacy of two of the most widely used antihypertensive drug classes, ACE inhibitors and ARBs, to reduce or treat inflammatory diseases such as atherosclerosis, arthritis, steatohepatitis, colitis, pancreatitis, and nephritis. 相似文献
83.
Bolun Cheng Xiao Liang Yan Wen Ping Li Lu Zhang Mei Ma Shiqiang Cheng Yanan Du Li Liu Miao Ding Yan Zhao Feng Zhang 《Journal of cellular biochemistry》2019,120(9):14831-14837
84.
85.
Xingbo Dang Gongliang Du Wei Hu Longyang Ma Pei Wang Yi Li 《Journal of cellular biochemistry》2019,120(1):544-551
86.
Mahsa Moeinian Amir Hossein Abdolghaffari Shekoufeh Nikfar Saeideh Momtaz Mohammad Abdollahi 《Journal of cellular biochemistry》2019,120(4):4766-4782
We aimed to review and meta-analyze the inflammatory and oxidative factors following alpha lipoic acid (ALA) and its derivative “andrographolid-lipoic acid-1” (AL-1) in ulcerative colitis (UC). ALA plays an important role in scavenging intracellular radicals and inflammatory elements. AL-1 is found in herbal medicines with potent anti-inflammatory properties. Data were collected from the Google Scholar, PubMed, Scopus, Evidence-based medicine/clinical trials, and Cochrane library database until 2017, which finally resulted in 22 animal studies (70 rats and 162 mice). The beneficial effects of ALA or AL-1 on the most important parameters of UC were reviewed; also, studies were considered separately in mice and rats. Administration of ALA and AL-1 significantly reduced the tumor necrosis factor-α level compared with the controls, while data were not noteworthy in the meta-analysis (mean differences = −18.57 [95% CI = −42.65 to 5.51], P = 0.13). In spite of insignificant decrease in meta-analysis outcomes (differences = 6.92 [95% CI = −39.33 to 53.16], P = 0.77), a significant reduction in myeloperoxidase activity was shown following ALA or AL-1 treatment compared with the controls. Despite significant differences in each study, we had to exclude some studies to homogenize data for meta-analyzing as they showed insignificant results. Interleukin 6, cyclooxygenase-2, glutathione, malondialdehyde, superoxide dismutase, histopathological score, macroscopic and microscopic scores, disease activity index, body weight change, and colon length were also reviewed. Most studies have emphasized on significant positive effects of ALA and AL-1. Comprehensive clinical trials are obligatory to determine the precious position of ALA or AL-1 in the management of UC. 相似文献
87.
88.
89.
Geraniol Averts Methotrexate-Induced Acute Kidney Injury via Keap1/Nrf2/HO-1 and MAPK/NF-κB Pathways
Nancy S. Younis Heba S. Elsewedy Tamer M. Shehata Maged E. Mohamed 《Current issues in molecular biology》2021,43(3):1741
Objectives: Geraniol, a natural monoterpene, is an essential oil component of many plants. Methotrexate is an anti-metabolite drug, used for cancer and autoimmune conditions; however, clinical uses of methotrexate are limited by its concomitant renal injury. This study investigated the efficacy of geraniol to prevent methotrexate-induced acute kidney injury and via scrutinizing the Keap1/Nrf2/HO-1, P38MAPK/NF-κB and Bax/Bcl2/caspase-3 and -9 pathways. Methods: Male Wister rats were allocated into five groups: control, geraniol (orally), methotrexate (IP), methotrexate and geraniol (100 and 200 mg/kg). Results: Geraniol effectively reduced the serum levels of creatinine, urea and Kim-1 with an increase in the serum level of albumin when compared to the methotrexate-treated group. Geraniol reduced Keap1, escalated Nrf2 and HO-1, enhanced the antioxidant parameters GSH, SOD, CAT and GSHPx and reduced MDA and NO. Geraniol decreased renal P38 MAPK and NF-κB and ameliorated the inflammatory mediators TNF-α, IL-1β, IL-6 and IL-10. Geraniol negatively regulated the apoptotic mediators Bax and caspase-3 and -9 and increased Bcl2. All the biochemical findings were supported by the alleviation of histopathological changes in kidney tissues. Conclusion: The current findings support that co-administration of geraniol with methotrexate may attenuate methotrexate-induced acute kidney injury. 相似文献
90.
650 nm激光穴位照射与针刺治疗良性前列腺增生症的疗效对比观察 总被引:1,自引:0,他引:1
目的:观察、评估650 nm激光照射穴位治疗良性前列腺增生症(中医辨证为肾阳虚)的临床疗效。方法:对30例良性前列腺增生症患者,采用650 nm激光,照射会阴、关元、肾俞,并随机选取30例,用针刺治疗作临床对比观察,针刺肾俞、秩边、关元、命门、足三里、脾俞、三阴交、次髎等穴。结果:激光照射穴位与针刺治疗均对良性前列腺增生症有较好的疗效,两组治疗前后症状评分、尿动力学均有显著的改变(P<0.05),但两者的临床疗效差异无统计学意义(P>0.05)。结论:650 nm激光穴位照射是临床治疗良性前列腺增生症(肾阳虚型)的有效治疗方法之一,值得深入研究。 相似文献